Ullah Mujib
Interventional Regenerative Medicine and Imaging Lab, Department of Radiology, School of Medicine, Stanford University, California, USA.
J Biomed Allied Res. 2020 Jun;2(1). doi: 10.37191/mapsci-2582-4937-2(1)-013. Epub 2020 Mar 16.
Stem cells are currently being used in many clinical trials for regenerative purposes. These are promising results for stem cells in the treatment of several diseases, including cancer. Nevertheless, there are still many variables which should be addressed before the application of stem cells for cancer treatment. One approach should be to establish well-characterized therapeutic stem cell banks to minimize the variation in results from different clinical trials and facilitate their effective use in basic and translational research.
目前,干细胞正被用于许多旨在实现再生目的的临床试验中。这些结果表明干细胞在治疗包括癌症在内的多种疾病方面颇具前景。然而,在将干细胞应用于癌症治疗之前,仍有许多变量需要解决。一种方法是建立特征明确的治疗性干细胞库,以尽量减少不同临床试验结果的差异,并促进其在基础研究和转化研究中的有效应用。